Publications:
|
|
|
May
2005
|
A
Cetylated Fatty
Acid Topical Cream
with Menthol Reduces
Pain and Improves
Functional Performance
in Patients
with Arthritis
- Published in
the Journal of Strength & Conditioning |
|
Feb
2005
|
Effects
of Treatment With
a Cetylated
Fatty Acid Topical
Cream on Static
Postural Stability
and Plantar Pressure
Distribution in
Patients With Knee
Osteoarthritis.
- Published in
the Journal of Strength & Conditioning |
|
Aug
5, 2004
|
The
effects of a
cetylated fatty
acid topical
cream on functional
mobility and
quality of life
of patients with
osteoarthritis.
- Published in the
Journal of Rheumatology |
|
| Oct
31, 2002 |
Distribution
of Cetylated
Fatty Acids in
Rats after Oral
or Topical Administration |
|
Oct
1, 2002
|
Digestion
and Metabolism
of Cetylated
Fatty Acids in
Rats |
|
| Sep
17, 2002 |
A
Preliminary Study
for the use of
Celadrin™ for
the Treatment
of Psoriasis |
|
| Feb
14, 2002 |
Cetylated
Fatty Acids Improve
Knee Function
in Patients with
Osteoarthritis
- Published
in the Journal
of Rheumatology |
|
| Aug
29, 2001 |
Evaluation
of a Topical
Cream containing
Cetylated Fatty
Acids |
|
| 2001 |
The
Effect of a Cetylated
Fatty Acid (CFA)
for Improving
Quality of Life
in Canines |
|
| 2001 |
A
fatty acid ester
(CMC) improves
quality of life
outcomes in osteoarthritis
(OA) patients. |
|
| |
|
| Scientific
Presentations: |
|
| 2003 |
The
effects of cetylated
fatty acid cream
on pain, range
of motion and quality
of life of patients
with osteoarthritis.
Kraemer WJ, Ratamess
NA, Anderson JA,
Tiberio DP, Joyce
ME, Messinger BN,
French DN, Sharman
MJ, Rubin MR, Gomez
AL, Volek JS, Hesslink
R Jr |
|
| 2003 |
The
effects of a cetylated
fatty acid cream
on functional mobility
and performance
in patients with
osteoarthritis.
Ratamess NA, Kraemer
WJ, Anderson JA,
Tiberio DP, Joyce
ME, Messinger BN,
French DN, Sharman
MJ, Rubin MR, Gomez
AL, Volek JS, Hesslink
R Jr. |
|
| 2003 |
Absorption
and metabolism
of a cetylated
fatty acid.
Islam A, Gallaher
C.M., and Gallaher
D.D. |
|
| 2002 |
Digestion
and metabolism
of cetylated fatty
acids in rats.
Gallaher D.D.,
Gallaher C.M.,
Hesslink R. Jr. |
|
| 2002 |
The
effects of a cetylated
fatty acid complex
on canine osteoarthritis.
Hesslink R.L.,
and Sprouse S |
|
| 2001 |
A
fatty acid ester
(CMC) improves
quality of life
outcomes in osteoarthritis
(OA) patients.
Barathur R.R.,
Bookout J.B., Sreevatsan
S, Freedland E.S.
and Hesslink Jr.,
R.L. |
|
| |
|
| Technical
Reports: |
|
| 2002 |
Bacterial
reverse mutation
Ames test screening.
MDS Pharma, Les
Oncins, France. |
|
| 2002 |
Evaluation
of topical cetylated
fatty acid application
to psoriasis patients.
Dermatologist Medical
Group of North
County, Inc. |
|
| 2001 |
The
acute toxicology
of oral cetylated
fatty acid gavage
CD-1 mouse model.
Perry Scientific,
Inc., |
|
| 2000 |
Evaluation
of a topical cream
containing cetylated
fatty acids using
hairless mouse
model.
Perry Scientific,
Inc., Study No.
00-1076. |
|
| |
